News

Authors of JAMA Oncology opinion piece see priorities set in response to the pandemic as a chance to discourage low-value cancer care.

Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars. 

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.

The veteran healthcare executive says this may be a Netflix vs. Blockbuster moment for hospitals. And health plans may be under pressure to meet the statutory levels for medical spending and recontract with their networks to offer enhanced payments in return for clinical improvement activities.

More than half of approximately 600 consumers (52%) surveyed in mid-March—the time when major metropolitan areas began issuing “shelter-in-place” orders and encouraging “social distancing”—said they had not been given direct guidance from either their payers or providers regarding the novel coronavirus.

Price of the drug to treat hospitalized patients revealed.

Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.

"I don't know about you, but in March I was scared; now I'm mostly depressed..."

Data to assess the prevalence and severity of COVID-19 among pregnant U.S. women and determine whether signs and symptoms differ among pregnant and nonpregnant women are limited, according to a report by the CDC.

Company's price is lower than ICER's $50k per-QALY assessment.

An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.

Penn's David Fajgenbaum, M.D., MBA, is branching out from Castleman disease to assemble comprehensive registry of drugs to treat COVID-19.

COVID-19 has applied a type of pressure on the U.S. this year that none of us have experienced in our lifetimes. Like every other segment of healthcare professionals, certified physician assistants have been put to the test during 2020.

The COVID-19 outbreak has tried the souls of people the world over, both personally and professionally, and healthcare executives are no exception. Despite seeing their plans and schedules torn up, executives can meet and master the unrelenting demands of leadership when a typical workday is anything but. Consider these tips from your industry peers to not just survive but also thrive — and to inspire your employees to do the same.

Farzad Mostashari and Ezekiel Emanuel agree: The COVID-19 experience could be what finally weans American healthcare off of its dependence on fee-for-service payment. But they have a slightly different vocabulary and different notions about what might lead to a tipping point.

COVID-19 forced a shift to virtual behavioral health therapy. Some once-skeptical providers, however, are finding telehealth beneficial. Reimbursement and continued relaxation of regulations will determine whether it’s here to stay.

John D'Amore, president and co-founder for Diameter Health, speaks with Managed Healthcare Executive Senior Editor, Peter Wehrwein, about fast healthcare interoperability resources standards , or FHIR, as they apply to insurers. There are new CMS FHIR regulations for Medicare Advantage and Medicaid managed care plans that go into effect in July 2021. Private insurers are expected to follow suit.

Strategic partnership combines software-as-a-service platform with locum tenens staffing to empower healthcare organizations of all sizes to measure, pinpoint and address clinician burnout.

Hospitals have bounced back from April but are still behind from where they were in May 2019.

One way the federal government responded to the COVID-19 pandemic was to temporarily increase the federal Medicaid matching rate by 6.2 percentage points. In exchange, states couldn’t add restrictions to eligibility and had to offer COVID-19 testing and treatment without cost sharing.

Demand for medications needed for patients who were intubated or put on a ventilator led to some shortages. The CARES Act has some provisions that may help deal with long-standing causes of the drug shortages that plague U.S. healthcare.

Early studies from China suggested that CT scans of the lungs could be used to diagnose the disease. But as PCR tests became available, radiology groups said CT scans should be used more sparingly and in confirmed cases.

A new handbook for facility managers and building owners offers in-depth guidance for how to ensure HVAC systems are properly maintained and upgraded to minimize virus spread.

These are the top 3 drugs recently approved — or soon to be approved by FDA — to watch in 2020.

A new report from the U.C. Berkeley Labor Center and Working Partnerships USA released today shows how technology is likely to impact job quality in healthcare and suggests that technological adoption may accelerate as a result of the COVID-19 pandemic.